Broadview Ventures

Broadview Ventures investment thesis

× Hewmun Lau, MBA Principal, Biopharma Team Hewmun Lau, MBA , is a Principal at Broadview Ventures. Hewmun shares responsibility for the day-to-day investment activities at Broadview Ventures, including identification and screening of new opportunities, due diligence, negotiation of deal structure, and portfolio company board involvement. Hewmun’s 15 years of experience in the life science industry spans across business development, commercial operations, consulting and R&D. Previously, Hewmun was at Merrimack Pharmaceuticals where she held several roles with increasing responsibility eventually serving as Director of Corporate Development where she led the company’s business development activities. Her prior positions within Merrimack include Associate Director of New Product Planning and

Broadview Ventures team (8)

Partners and principals at Broadview Ventures:

• Maria Berkman — sweet spot $1.5M
• Christopher Colecchi — sweet spot $1.5M
• Christopher de Souza — sweet spot $1.5M
• Daniel Gottlieb — sweet spot $1.5M
• Benjamin Kreitman — sweet spot $1.5M
• Hewmun Lau — sweet spot $1.5M
• Thomas Needham — sweet spot $1.5M
• David Prim — sweet spot $1.5M

Broadview Ventures portfolio companies

Companies listed on Broadview Ventures's public materials include: Team, Portfolio, Press, All, Category Medtech BioPharma, Category, Medtech, BioPharma, Status Active Exited, Status, Active, Exited, Acquired by Boston Scientific, Reverse Merger (Nasdaq: Capr), Acquired by Edwards Lifesciences, IPO (Nasdaq: Lyra), Reverse Merger (Nasdaq: VRDN), Acquired by Undisclosed Company, Acquired by Mesoblast, Out-license / Exited to Gossamer, Acquired by Biogen, Acquired by Rocket Pharma (Nasdaq: RCKT), http://www.acesionpharma.com/, http://www.adientmedical.com/, https://www.aeromics.com/, http://aggamin.com/, https://www.alleviantmedical.com/, https://www.alveron.com, https://www.antagtherapeutics.com, https://ascensionventures.org/our-companies/apama-medical/, https://ariacv.com/, https://www.atacor.com/, https://www.baskingbiosciences.com/, http://www.biokier.com/, https://capricor.com/, https://www.maxwellbiomedical.com/about-cardialen, https://cardiosense.com, https://comanchebiopharma.com, https://corflow.com, https://www.croivalve.com/, http://www.decimmune.com/, https://coridea.com/, https://epirium.com/, http://fineheart.fr/, https://www.giwindows.com/, http://gilatherapeutics.com/, https://www.hayatx.com, https://herantis.com/, https://infobionic.com/, https://i3-nirf.com/, https://www.ischemiacare.com/, https://isomab.bio, https://lyratherapeutics.com/, https://mellitushealth.com, https://www.viridiantherapeutics.com/, https://mosanna.com/, https://www.nupulsecv.com/, https://nyramedical.com, http://pulmokine.net/, https://www.puzzlemed.com.

Is Broadview Ventures a fit for your round?

Upload your pitch deck and see whether anyone at Broadview Ventures appears in your top matches.